Drugs Made In America Acquisition (DMAA) Competitors $10.26 -0.01 (-0.10%) As of 03:57 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsOwnershipSEC FilingsShort InterestTrendsBuy This Stock DMAA vs. BRDG, SBR, SAFE, DEA, ORC, PAX, PLYM, CSR, UNIT, and FBRTShould you be buying Drugs Made In America Acquisition stock or one of its competitors? The main competitors of Drugs Made In America Acquisition include Bridge Investment Group (BRDG), Sabine Royalty Trust (SBR), Safehold (SAFE), Easterly Government Properties (DEA), Orchid Island Capital (ORC), Patria Investments (PAX), Plymouth Industrial REIT (PLYM), Centerspace (CSR), Uniti Group (UNIT), and Franklin BSP Realty Trust (FBRT). These companies are all part of the "trading" industry. Drugs Made In America Acquisition vs. Its Competitors Bridge Investment Group Sabine Royalty Trust Safehold Easterly Government Properties Orchid Island Capital Patria Investments Plymouth Industrial REIT Centerspace Uniti Group Franklin BSP Realty Trust Bridge Investment Group (NYSE:BRDG) and Drugs Made In America Acquisition (NASDAQ:DMAA) are both small-cap trading companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, media sentiment, valuation, risk, dividends and analyst recommendations. Do institutionals and insiders hold more shares of BRDG or DMAA? 52.8% of Bridge Investment Group shares are owned by institutional investors. 65.9% of Bridge Investment Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Do analysts recommend BRDG or DMAA? Bridge Investment Group currently has a consensus price target of $10.70, suggesting a potential upside of 13.11%. Given Bridge Investment Group's stronger consensus rating and higher possible upside, research analysts plainly believe Bridge Investment Group is more favorable than Drugs Made In America Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bridge Investment Group 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Drugs Made In America Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has stronger valuation and earnings, BRDG or DMAA? Bridge Investment Group has higher revenue and earnings than Drugs Made In America Acquisition. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBridge Investment Group$397.73M2.96$8.01M-$0.42-22.52Drugs Made In America AcquisitionN/AN/AN/AN/AN/A Is BRDG or DMAA more profitable? Drugs Made In America Acquisition has a net margin of 0.00% compared to Bridge Investment Group's net margin of -3.03%. Bridge Investment Group's return on equity of 8.42% beat Drugs Made In America Acquisition's return on equity.Company Net Margins Return on Equity Return on Assets Bridge Investment Group-3.03% 8.42% 3.36% Drugs Made In America Acquisition N/A N/A N/A Does the media refer more to BRDG or DMAA? In the previous week, Drugs Made In America Acquisition's average media sentiment score of 1.91 beat Bridge Investment Group's score of 0.00 indicating that Drugs Made In America Acquisition is being referred to more favorably in the news media. Company Overall Sentiment Bridge Investment Group Neutral Drugs Made In America Acquisition Very Positive SummaryBridge Investment Group beats Drugs Made In America Acquisition on 7 of the 9 factors compared between the two stocks. Get Drugs Made In America Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for DMAA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DMAA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DMAA vs. The Competition Export to ExcelMetricDrugs Made In America AcquisitionInvestment Offices IndustryFinancial SectorNASDAQ ExchangeMarket Cap$299.59M$195.88M$6.48B$10.49BDividend YieldN/AN/A4.33%4.70%P/E RatioN/AN/A1,793.0526.30Price / SalesN/AN/A1,359.80125.95Price / CashN/A37,149.00127.9461.38Price / BookN/AN/A2.116.41Net IncomeN/A-$160K$1.23B$276.84M7 Day Performance-0.48%0.01%3.46%-0.02%1 Month Performance0.10%1.33%5.79%6.96%1 Year PerformanceN/A8.33%34.45%29.86% Drugs Made In America Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DMAADrugs Made In America AcquisitionN/A$10.26-0.1%N/AN/A$299.59MN/A0.002Positive NewsBRDGBridge Investment Group2.2197 of 5 stars$9.46-1.9%$10.70+13.1%-4.2%$1.18B$397.73M-22.522,250High Trading VolumeSBRSabine Royalty Trust1.575 of 5 stars$81.50+0.9%N/A+29.1%$1.18B$83.17M16.172,020Positive NewsSAFESafehold3.9263 of 5 stars$15.31-1.9%$20.25+32.3%-41.0%$1.12B$365.68M10.71120Analyst ForecastDEAEasterly Government Properties3.4326 of 5 stars$22.81+0.3%$27.15+19.1%-32.4%$1.03B$302.05M55.6250Positive NewsORCOrchid Island Capital3.8465 of 5 stars$7.00+0.5%N/A-14.5%$1.02B$241.58M34.982,018Positive NewsPAXPatria Investments1.9984 of 5 stars$14.79+0.1%$14.00-5.3%+30.7%$983.86M$397.50M29.58390PLYMPlymouth Industrial REIT3.1563 of 5 stars$21.76-0.9%$21.33-1.9%-1.2%$977.96M$198.35M7.5540CSRCenterspace3.2876 of 5 stars$57.86-0.6%$68.75+18.8%-16.3%$975.07M$260.98M-32.15470Positive NewsAnalyst ForecastUNITUniti Group1.9621 of 5 stars$6.22-3.0%$6.70+7.7%+8.5%$948.58M$1.17B22.61750FBRTFranklin BSP Realty Trust3.9412 of 5 stars$11.24+0.4%$14.67+30.5%-16.9%$920.66M$210.45M11.47N/A Related Companies and Tools Related Companies BRDG Alternatives SBR Alternatives SAFE Alternatives DEA Alternatives ORC Alternatives PAX Alternatives PLYM Alternatives CSR Alternatives UNIT Alternatives FBRT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DMAA) was last updated on 10/1/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredTrump is Fast-Tracking These Three CompaniesThe Trump administration is planning to invest DIRECTLY in a small sector of the stock market… And they just r...InvestorPlace | SponsoredTrump’s “Smart Dollar” just went mainstream"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Drugs Made In America Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Drugs Made In America Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DMAA Stock Alerts